Breaking

Crowd crushes at two charity events in Nigeria kill at least 32 people
Small plane crashes into Brazilian tourist city, killing at least 10
Albania bans TikTok for a year after killing of teenager
Anti-immigrant anger rises at scene of German market attack
‘Her Story’: China’s answer to ‘Barbie’ becomes latest smash hit. But some men are not amused
After years of war, 6.8 million Ukrainian refugees’ lives are still mired in uncertainty
Palestinian Authority unable to dislodge militants in sprawling West Bank camp
Ex-US fighter pilot accused of training Chinese military to be extradited to the United States

World
Business
Politics
Investing
Search for:

Investing

RAD 202 receives approval to start Phase 1 therapeutic trial

December 20, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced RAD 202 receives approval to start Phase 1 therapeutic trial

Download the PDF here.

This post appeared first on investingnews.com

0

Related Posts

Lac Carheil Expanded Footprint, Drilling Fully Permitted

December 23, 2024

Stardust Power Acquires Site, Receives Key Permit And Receives Approval For Major Construction To Commence

December 22, 2024

Tech 5: Bitcoin Drops Below US$100,000, Micron Guidance Shakes Investors

December 22, 2024

Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (65)
- Investing (212)
- Politics (257)
- World (274)

Disclaimer: SecureWealthAdvisor.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2024 SecureWealthAdvisor.com | All Rights Reserved

Top

World
Business
Politics
Investing

Type above and press Enter to search. Press Esc to cancel.